Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer.
Saved in:
| Title: | Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer. |
|---|---|
| Authors: | Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Soto F; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xu T; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wilson N; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Franco-Vega MC; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Simbaqueba Clavijo CA; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shannon VR; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Faiz SA; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gandhi S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin SH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lopez P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhong L; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Akhmedzhanov F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Godoy MCB; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shroff GS; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu J; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khawaja F; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kim ST; Department of Rheumatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daniel-Macdougall C; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liao Z; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sheshadri A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: asheshadri@mdanderson.org. |
| Source: | Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2023 Oct; Vol. 35 (10), pp. 630-639. Date of Electronic Publication: 2023 Jul 14. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: W.B. Saunders Country of Publication: England NLM ID: 9002902 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2981 (Electronic) Linking ISSN: 09366555 NLM ISO Abbreviation: Clin Oncol (R Coll Radiol) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
